Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShares OutstandingShares Outstanding
Ratios

Sangamo Therapeutics (SGMO) Receivables - Net (2016 - 2025)

Sangamo Therapeutics (SGMO) has disclosed Receivables - Net for 16 consecutive years, with $371000.0 as the latest value for Q4 2025.

  • For Q4 2025, Receivables - Net fell 25.8% year-over-year to $371000.0; the TTM value through Dec 2025 reached $371000.0, down 25.8%, while the annual FY2025 figure was $371000.0, 25.8% down from the prior year.
  • Receivables - Net hit $371000.0 in Q4 2025 for Sangamo Therapeutics, down from $523000.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $10.5 million in Q3 2024 and bottomed at $366000.0 in Q1 2025.
  • Average Receivables - Net over 5 years is $3.7 million, with a median of $3.2 million recorded in 2022.
  • Year-over-year, Receivables - Net soared 814.29% in 2024 and then crashed 95.02% in 2025.
  • Sangamo Therapeutics' Receivables - Net stood at $6.0 million in 2021, then plummeted by 38.47% to $3.7 million in 2022, then crashed by 75.05% to $923000.0 in 2023, then crashed by 45.83% to $500000.0 in 2024, then dropped by 25.8% to $371000.0 in 2025.
  • According to Business Quant data, Receivables - Net over the past three periods came in at $371000.0, $523000.0, and $372000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.